» Articles » PMID: 30989484

The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia

Overview
Journal J Urban Health
Publisher Springer
Specialty General Medicine
Date 2019 Apr 17
PMID 30989484
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

People who inject drugs (PWID) are disproportionately represented among individuals who experience imprisonment and often have more complex physical and mental health needs than people in prison without injecting histories. The trajectories of PWID after prison release are poorly understood, hampering the development of effective strategies to address their distinct health needs. The Prison and Transition Health (PATH) Cohort Study is characterising the post-release trajectories of incarcerated male PWID in Victoria, Australia. We outline study methodology and baseline characteristics of participants prior to their release. Four hundred participants were recruited from three prisons and completed researcher-administered baseline interviews covering socio-demographics, social supports, physical health, mental health, alcohol and other drug use, and pre-release and transitional service utilisation. The median age among participants was 36 years (IQR 30-42), and they reported a median of five (IQR 3-9) previous adult incarcerations. Almost half (49%) were reliant on government payments prior to incarceration. One quarter (25%) of participants reported removal from their parents' care as children and 64% reported being a parent or primary caregiver to children. Most participants (81%) reported a previous mental health diagnosis and 44% reported three or more diagnoses. The most common drugs injected prior to incarceration were crystal methamphetamine (80%) and heroin (62%), and most (85%) reported being under the influence of drugs at the time of committing offences for which they were currently incarcerated. Injecting drug use during their current sentence was reported by 40% of participants, and 48% reported engaging with some form of drug treatment during their current sentence. Study participants are characterised by significant mental health and substance use morbidities, social disadvantage and criminogenic histories that present challenges for the provision of post-release support services. Data from the PATH Cohort Study will help inform strategies to improve the health and social outcomes of this population.

Citing Articles

Cost-benefit analysis of Canada's Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections.

Houdroge F, Kronfli N, Stoove M, Scott N CMAJ. 2024; 196(43):E1401-E1412.

PMID: 39681365 PMC: 11649329. DOI: 10.1503/cmaj.240648.


Associations Between Supported Accommodation and Health and Re-offending Outcomes: a Retrospective Data Linkage Study.

Gibbs D, Colledge-Frisby S, Farnbach S, Doyle M, Shakeshaft A, Larney S J Urban Health. 2024; 101(1):80-91.

PMID: 38349583 PMC: 10897077. DOI: 10.1007/s11524-023-00824-w.


HIV policies in Australian prisons: a structured review assessing compliance with international guidelines.

Simpson P, Gardoll B, White L, Butler T Lancet Reg Health West Pac. 2024; 41:100813.

PMID: 38223398 PMC: 10786648. DOI: 10.1016/j.lanwpc.2023.100813.


The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review.

Gibbs D, Stockings E, Larney S, Bromberg D, Shakeshaft A, Farnbach S Harm Reduct J. 2023; 20(1):91.

PMID: 37480060 PMC: 10362610. DOI: 10.1186/s12954-023-00832-8.


The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia.

Gunn J, OKeefe D, Draper B, Djordjevic F, Ryan K, Kerr P BMJ Open. 2023; 13(7):e071665.

PMID: 37400235 PMC: 10335404. DOI: 10.1136/bmjopen-2023-071665.


References
1.
Hellard M, Hocking J, Crofts N . The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect. 2004; 132(3):409-15. PMC: 2870120. DOI: 10.1017/s0950268803001882. View

2.
Kariminia A, Butler T, Corben S, Levy M, Grant L, Kaldor J . Extreme cause-specific mortality in a cohort of adult prisoners--1988 to 2002: a data-linkage study. Int J Epidemiol. 2006; 36(2):310-6. DOI: 10.1093/ije/dyl225. View

3.
Kariminia A, Butler T, Levy M . Aboriginal and non-Aboriginal health differentials in Australian prisoners. Aust N Z J Public Health. 2007; 31(4):366-71. DOI: 10.1111/j.1753-6405.2007.00089.x. View

4.
Freudenberg N, Moseley J, Labriola M, Daniels J, Murrill C . Comparison of health and social characteristics of people leaving New York City jails by age, gender, and race/ethnicity: implications for public health interventions. Public Health Rep. 2007; 122(6):733-43. PMC: 1997241. DOI: 10.1177/003335490712200605. View

5.
Farrell M, Marsden J . Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction. 2008; 103(2):251-5. DOI: 10.1111/j.1360-0443.2007.02081.x. View